Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Brain & Neurology

Brain Photobiomodulation Improves Sleep Quality in Subjective Cognitive Decline: A Randomized, Sham-Controlled Study

After five days of PBM therapy targeting the prefrontal cortex, sleep efficiency and N-back cognitive performance were improved on the fifth day.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors randomized 58 people with subjective cognitive decline to real or sham transcranial brain photobiomodulation for six consecutive days, recording sleep and working memory on n-back tasks. They report no between-group difference in sleep efficiency, REM percentage or wake-up time, but better n-back accuracy and reaction time in the real-light group. The abstract does not state the trial's long-term effects or clinical significance.

Participants
58
Who or what was studied
Adults with subjective cognitive decline
Limits stated in the abstract
The abstract reports no between-group sleep differences overall, and the sleep improvements were seen only within the real-light group on day five.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.

Record from PubMed, a service of the National Library of Medicine.

How to read a trial: what to check before relying on this kind of research.

Terms in this paper: Photobiomodulation, Cognitive decline, Sham, Control group, Biomarker. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies

Brain & Neurology

A multimodal evaluation of transcranial photobiomodulation in mild cognitive impairment: Cognitive, metabolic, and neuroimaging outcomes of a pilot randomized controlled trial

Cognitive, metabolic, and network-level findings are consistent with enhanced mitochondrial efficiency and anti-inflammatory effects. These results support larger, double-blind, multicenter trials to evaluate tPBM as a mitochondria-targeted therapy in early ADRD.

Trial · June 3, 2026 · Rashidi-Ranjbar N et al.